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African sleeping sickness. Tsetse fly. Trypanosomes. To
some, these words may sound exotic, menacing or even
humorous, but not to me. The biochemistry and physi-
ology of African trypanosomes, and particularly
Trypanosoma brucei, the protozoan agent of this deadly
scourge, has been the main focus of my research life and
thought for almost 25 years. My current work focuses
on the mechanisms by which trypanosomes attach to
and interact with host cells, and the potentially toxic
molecules involved in such interactions. As a new facul-
ty member at BSC, I’d like to introduce you to this
organism and the disease it causes, and point out ways
in which the study of these parasites by students can
offer them valuable research experience. 
Training in microbiology and biochemistry prepared 
me well for the study of trypanosomes, but lab-bench
scientific studies are only one aspect of  understanding
this disease and the problems it causes throughout
much of the African continent. Geography, colonial his-
tory, ethnic conflicts, and cultures of the region all
influence the toll this disease takes. 
HISTORY AND EPIDEMIOLOGY
OF AFRICAN SLEEPING SICKNESS
African sleeping sickness in humans is caused by a pro-
tozoan, Trypanosoma brucei, and, throughout much of
sub-Saharan Africa, is transmitted by the bite of the
tsetse fly. Although mortality is relatively low in num-
bers compared to diseases caused by other infectious
agents, it is sufficient for the disease to be a major
health threat and concern. Trypanosoma brucei, the 
parent species, is found in antelopes and other game
animals, but these native animals (and even some local
breeds of domestic cattle) can tolerate the infection
without showing symptoms. However, they may 
serve as reservoirs of infection for the trypanosome 
subspecies which attack humans. We do not know
what makes the wild antelope population resistant, 
but assume that millions of years of co-evolution have
allowed it to reach a stale-mate with the parasite.
Almost as important as the disease in humans is the dis-
ease in domestic animals which, by killing animals of
European (i.e., non-native) stock, prevents cultivation
of, or grazing on, millions of acres of fertile land in the
“tsetse belt.” Some trypanosome species affect cattle;
others, horses and camels. Together these organisms
make farming and ranching difficult in the most poten-
tially productive area of the continent. A major protein
deficiency in the African diet, caused by the inability to
produce sufficient food for the population, might be
averted if some of this land (in an area the size of the
US) could be maintained for farming and grazing. 
THE VECTOR
Tsetse fly is a general name for any of the eight species
of the genus Glossina which may carry and transmit the
parasite. The flies are generally divided into two broad
groups—those which live in the riverine areas of the
rain forests of West Africa  and are associated with the
chronic form of the disease caused by T. brucei gambi-
ense, and the woodland tsetses,  which inhabit drier
grasslands and forests of the east coast of Africa  and are
vectors for the more acute, and more rapidly fatal, form
of the disease caused by T. brucei rhodesiense. Indigenous
peoples have known for centuries that the presence of
the tsetse fly is associated with high incidence of dis-
ease. Regions which are endemic for the flies are also
endemic for sleeping sickness, which is essentially 100%
fatal if untreated. Traditionally, native herdsmen have
moved their cattle away from the rivers during the
tsetse season, minimizing  the effects of the disease.
Colonial powers actually helped spread the disease
across the continent by providing host animals in their
horses and cattle, so what was once a contained,
endemic problem soon became widespread throughout
the continent.
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PATHOLOGY OF THE DISEASE
AND CURRENT DRUG TREATMENTS
After the fly bites, trypanosomes enter the mammalian
host, multiply in the skin, then migrate through the tis-
sues to the bloodstream. Most of their life cycle in the
mammalian host occurs in the blood and tissues, with
rapid cell division leading to high parasite levels. This is
the primary stage of the disease, when available drug
treatments are most likely to be effective. It is also a
time when the bite of another tsetse fly can transmit
these parasites to the next host. However, the disease
may progress to the secondary stage when the parasites
migrate from the blood into the central nervous system,
including the brain and cerebrospinal fluid. Early indica-
tors may be mild episodes of disorientation which then
progress to an increasingly altered sleep cycle resulting
in long periods of “sleep” and eventually coma and
death. 
The drugs available to treat the primary infection have
not changed in 100 years. Pentamidine and suramin,
which kill the parasite, are still effective against the
bloodstream forms (although some strains have become
resistant) but have side effects. Melarsoprol, an arseni-
cal which until recently was the only drug for treating
cerebral involvement, is toxic enough on its own to
account for a 5% fatality rate. The only drug recently
developed (in the 1980’s) to treat secondary stage dis-
ease, eflornithine, an inhibitor of an essential pathway
of parasite metabolism, was discontinued by its manu-
facturer after a company merger. This points up a criti-
cal problem in the development of new treatments for
the disease. Pharmaceutical companies are unwilling
and/or unable to devote resources to research and devel-
opment of new drugs because the disease strikes in areas
where the infected individuals are unable to afford the
price of medication. In addition, an effective distribu-
tion system may be unavailable even if the drug is
donated free of charge by the manufacturer. 
STRATEGIES FOR PREVENTION AND CONTROL
Although the latest  World Health Organization statis-
tics record only about 40,000 reported cases, this is
probably a gross under-representation. As many as half
a million people may currently be infected, but most
cases go unreported and untreated because the rural
populations which are most at risk may have minimal
contacts with healthcare personnel. Also, infected indi-
viduals may seek treatment only at later stages of the
disease or not at all. Many are children who die of  try-





areas have been  suc-
cessful strategies for
control in the past,
almost eradicating 
the disease in the half
century prior to the
1970’s. Unfortunately,
surveillance as a con-
trol measure relies on
successful administra-
tive infrastructures and
economics because it is a  labor-intensive activity.
Surveillance teams must cover vast areas to diagnose
the disease where infection rates are highest, must take
blood samples from individuals in  villages where, in
some cases, 70% of the population may be infected, and
finally, must arrange for contact with healthcare deliv-
ery systems which are often inadequate. Patients must
be transported to hospitals where the drugs are general-
ly administered intravenously. This removal of infected
persons from a community has the public health effect
of removing a reservoir of infection, and may help cut
down on transmission but may be a “hard sell” to fami-
lies of infected individuals. In the past, successful con-
trol strategies have also involved the labor-intensive
collection and removal of the flies when they are active
during the daylight hours.  Broader strategies such as
spraying insecticides or converting riverine areas and
woodlands into farmland have also been effective.
However, these are often threatening to the delicate
ecological balance of an area and, in any case, also rely




The life cycle of the
African trypanosome
in the mammalian host
and in the tsetse fly host.
Shown are the various
morphological forms
seen in each, as well as
the phenomenon of anti-
genic variation (altered
surface proteins) seen in
the mammalian host.
Figure courtesy of  Dr.
James E. Strickler ©






























THE GEOPOLITICS AND DEVASTATING CONSEQUENCES
OF THE DISEASE
In the past 40 years the legacy of colonial rule has
resulted in economic and political changes, ethnic
unrest, civil wars, population migrations due to famine
and other non-biological events which have subjected
the population in sub-Saharan Africa to reduced levels
of surveillance, minimal treatment, and subsequent
dramatic increases in the incidence and mortality of
sleeping sickness. The boundaries of countries which
are affected by these problems, including (but not limit-
ed to) the Democratic Republic of the Congo, Sudan,
Uganda and Angola, can be superimposed upon recent
data recording epidemic resurgence of this disease.
Even countries with stable political and economic
structure are at risk of increased incidence due to the
thousands of refugees who may carry the disease across
national borders. Few countries are equipped to deal
with the magnitude of such a problem.
HOW UNDERGRADUATES BENEFIT
FROM RESEARCH ON MICROBIAL SYSTEMS
Laboratory research with trypanosomes provides a
meaningful experience for undergraduate students for
several reasons. Trypanosomes offer a system for study
very similar to that of other biological systems: non-
infectious laboratory strains of the parasites can now be
studied using all the methods of modern biochemistry
and molecular biology to grow and manipulate try-
panosomes, and these methods are applicable to
research on other organisms. Students entering the job
market directly after college will be well prepared with
“hands-on” experience for jobs in biotechnology or
pharmaceutical companies, or in academic research,
hospital and/or government labs. And some undergrad-
uate research is almost always a prerequisite for admis-
sion to good graduate and professional programs.
Admissions committees are impressed by the level of
technical expertise and commitment exemplified by
students who do “bench level” research. Additionally,
the ability to think logically in order to design, execute,
analyze and write up experiments is useful for many
future scientific or nonscientific endeavors.  Studies on
trypanosomes overlap with research in genetics, cell
and molecular biology, immunology and biochemistry
currently being undertaken in the Biology and
Chemistry departments at BSC. This promotes a level
of camaraderie here among undergraduate researchers
which is useful when they enter the professional world.
But there is a more important reason for doing research
on any parasite agent of diseases which afflict primarily
developing countries. Microorganisms have always
affected the course of human society—consider the
effects of  plague, typhus, typhoid, dysentery, and
tetanus during wars, or cholera epidemics in cities and
rural areas, or the Irish potato famine, which brought so
many individuals to the United States during the mid-
19th century. Students at BSC studying trypanosomes
learn valuable lessons in public health. Increased aware-
ness of public health and environmental issues both
locally and worldwide helps them understand the inter-
play between individual actions within the society and
the spread of microorganisms and disease, as well as the
effect that microorganisms have on the course of a soci-
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ety’s progress as a whole. Ultimately the control and
eventual eradication of African sleeping sickness and its
companion diseases, malaria, hookworm, leishmaniasis,
schistosomiasis, and more, will depend  both on the sci-
ence and on the social factors which influence how indi-
viduals in a community or a country interact with one
another and with the disease agent. 
WHAT TO DO? STRATEGIES FOR UNDERSTANDING THE
PARASITE AS A MEANS OF COMBATING THE DISEASE
Understanding  the parasite’s physiology and biochem-
istry  (in other words, “know thine enemy”), can help
researchers to develop a rational approach to prevention
or therapy. Trypanosomes have so far evaded most
attempts to control and  understand them. Through
millions of years of co-evolution with their mammalian
hosts, the parasites which survive rely on “immunocon-
fusion” and “immunoevasion,” mechanisms which
allow them to be overlooked by the immune system. In
addition, the metabolism of the parasite closely mimics
the metabolism of its mammalian hosts, another sur-
vival advantage, so drugs for treating the disease have a
very narrow window of effectiveness for eradicating the
parasite without causing damage to the patient. 
In order to develop new and effective drugs, we will
have to find an Achilles’ Heel in the parasite, i.e., a
metabolic variation found only in the parasite and not
in the host, which might be exploited for drug therapy
without damage to the host physiology. A thorough
knowledge of the parasite’s physiology and biochem-
istry is one way to find this difference, but even this
straightforward approach has been hampered for many
years by the inability to study the parasite effectively.
Once removed from the host animal, the trypanosome
is a fragile creature, difficult to keep alive in the lab. In
recent years there have been advances in the ability to
culture the parasite and to study its genes and their
expression or activation using molecular biological tech-
niques in addition to traditional biochemical and
immunological methods. This has allowed us to pro-
duce sufficient quantities of this organism or its protein
components to examine their functions more carefully,
a first step in designing specific drugs to block those
functions and kill the parasite. However, we still have
few clues as to how the parasite actually kills its host. Is
its simple presence in large numbers sufficient to inter-
fere with the host’s own metabolism? Does it produce
toxic substances that directly kill host cells, damaging
functions of critical organs ? Does it actively inhibit cer-
tain components of the immune system? How does it
migrate through tissues to the small capillaries of the
bloodstream, and from there to the brain?  These are
some of the questions which need to be addressed by
studying the biochemistry of the trypanosome’s com-
ponents and how they work. 
Any projects undertaken by BSC students must  be safe,
and there are now culture systems which use a form of
the parasite which is non-infectious for humans. These
allow growth of sufficient numbers of cells for students
to study their interactions with mammalian or insect
cells in culture. Special dyes can now be used to stain
different physiological states of parasite or host to
assess adherence or production of toxic substances. In
addition, students can learn how to clone and detect
specific parasite genes and produce their proteins in 
the lab to help in identifying novel drugs to inhibit 
well known proteins, or to find unique proteins as 
novel drug targets in the parasite. Newer purification
methods allow both isolation of the proteins and identi-
fication of their functions, providing many potential
projects for student focus. In the past ten years, several
types of cell surface enzymes, receptor molecules, adhe-
sion proteins, stress-related proteins and other impor-
tant molecules have been identified in trypanosomes 
as potential targets. Unraveling the components of the
parasite provides enough work for many students to
participate in helping us to understand and control 
this disease.
—Patricia E. Mancini is Assistant Professor 
of Biological Sciences
